Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

(a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future ...

The emerging opportunity to accelerate drug discovery with AI and machine learning (AI/ML) is clear. “Wherever we look in the drug development pipeline, we find AI or the desire to use it,” says David ...

This analysis is by Bloomberg Intelligence Industry Analyst Andrew Galler and Senior Associate Analyst Jack Maltby. It appeared first on the Bloomberg Terminal. Life sciences is among the most ...